Difference between revisions of "Ubiquitin"
m |
|||
Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
− | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Ubiquitin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 26: | Line 26: | ||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
− | | [[ | + | | [[TG2 reactive residues (Ubiquitin)|K29, K48]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence |
Revision as of 11:27, 31 August 2007
Template:Infobox header| Ubiquitin | |
---|---|
Substrate peptide name | Ubiquitin |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Cytosol |
Swissprot ID | P62988 |
Reactive glutamines | - |
Reactive lysines | K29, K48 |
Substrate sequence | ENVKAKIQDKE
LIFAGKELRDG |
Structure | 1UBQ |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:15132984 |
Notes | |
Template:Infobox header | |